The Sage Group

Peripheral Arterial Disease (PAD) Interventional Market Analysis. Primary and Provisional Stenting

This report is one of three new publications that examine interventional procedures employed to treat lower limb arterial disease. Procedures include revascularization with surgery or endovascular devices, as well as amputation.

Employing ICD-9 procedure data, PAD Interventional Market Analysis Based on Primary and Provisional Stenting provides a comprehensive examination of the following topics: an overview of the 2005 inpatient interventional market by type of procedure and vascular territory; an in-depth analysis of 2005 revascularization procedures in the aortoiliac, femoropopliteal and tibioperoneal regions; an examination of amputation by type of procedure and territory; an analysis of inpatient and outpatient endovascular procedures by type and vascular territory and forecasts of endovascular procedures through 2020 by device type and territory.

This analysis examines the PAD interventional market based on primary and provisional stenting. For comparative purposes, overviews of the endovascular market with primary stents only and the interventional market with primary stents by type of procedure are included.

The report provides extensive annual data, including the estimated number of people in the U.S. with PAD in the 2000-2020 periods and the U.S. PAD revascularization market for surgical and endovascular procedures in the 2000-2020 periods. Based on two alternative technological scenarios, angioplasty/atherectomy, primary stent procedures and provisional stent procedures are projected through 2020 in the aortoiliac, femoropopliteal and tibioperoneal vascular regions. The optimistic case reflects primary stenting gaining share and provisional stenting increasing as a percentage of angioplasty/atherectomy procedures, while in the pessimistic case primary stenting declines and provisional stenting is held at a constant percentage of angioplasty/atherectomy procedures.

An evaluation of the dollar value of the current endovascular device market is also included, which features a comparison of size and share by device type in 1997, 2003 and 2005.

Price: $4,400

To purchase call us at 404 520-6652 or